首页> 外文会议>Pacific basin nuclear conference >CANADA'S ONGOING ROLE IN GLOBAL MEDICAL ISOTOPE SUPPLY
【24h】

CANADA'S ONGOING ROLE IN GLOBAL MEDICAL ISOTOPE SUPPLY

机译:加拿大在全球医疗同位素供应中的持续作用

获取原文

摘要

For more than sixty years, Canada has been at the forefront of research and development, technology, and production of medical isotopes. The combination of a strong national nuclear R&D program, innovation from industry and an ongoing commitment to safety and security has created a leadership position envied by many. Despite the many challenges associated with manufacturing a product that is not only radioactive, but in many cases subject to medical regulations and shipping this product around the world, Canada's stronghold in terms of technology and expertise actually positions us quite well to continue growing our international presence. Canada is now at a turning point, and must make critical decisions regarding the future of both the nuclear R&D and power generation infrastructure, which will ultimately affect the country's ability to remain competitive in the medical isotope field. Only through ongoing investment and supporting policy will we continue to be able to contribute in such a meaningful way to not only the lives of Canadians, but to millions of people around the world.
机译:六十多年来,加拿大一直处于医学同位素研究,开发,技术和生产的最前沿。强大的国家核研发计划,行业创新和对安全与安保的持续承诺相结合,创造了许多人羡慕的领导地位。尽管制造不仅具有放射性,而且在许多情况下还必须遵守医疗法规并在全球范围内运输该产品的过程中面临许多挑战,但加拿大在技术和专业知识方面的据点实际上使我们处于良好地位,可以继续发展我们的国际影响力。加拿大现在处在一个转折点,必须就核研发和发电基础设施的未来做出重要决定,这最终将影响该国在医学同位素领域保持竞争力的能力。只有通过持续的投资和支持政策,我们才能继续以有意义的方式为加拿大人民乃至全世界数百万人的生活做出贡献。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号